Menu
Advanced, culture-free, AI/ML based UTI Diagnostic Tool
for a new era of Anti Microbial Resistance Management
Immediate insights into potential infections and resistance patterns.
Application is useful
in both human and
veterinary medicine.
Supports clinicians with
data-driven recommendations for antibiotic prescriptions.
Eliminates the need for traditional, time-consuming
lab cultures.
Provides a probability score indicating the causative organism, likelihood of antibiotic resistance, and AMR genes.
Clinicians input patient clinical history into AMRx®.
The AI system processes the data to predict potential AMR risks.
Provides a probability score indicating the causative organism, likelihood of antibiotic resistance, and AMR genes.
Offers recommendations for personalised, evidence-based treatment.
Clinicians input patient data into AMRx®.
The AI system processes the data to predict potential AMR risks.
Provides a probability score indicating the likelihood of resistance.
Offers recommendations for tailored, evidence-based treatment.
AMRx®: A game changer in infectious disease diagnostics and Management
AMRx® is first-of-its-kind and stands out as a leader in the field of infectious disease diagnostics due to its unique combination of in-vitro and in-silico capabilities:
AMRX® is a groundbreaking innovation in the fight against Antimicrobial Resistance (AMR). It is a culture-free diagnostic tool designed to predict bacterial infections, causative organism, and AMR with very high accuracy. This revolutionary approach eliminates the need for traditional lab cultures, providing rapid, reliable results that are crucial for timely and effective treatment.
Backed by a provisional patent (Application no – 202241041495), AMRx® represents a significant leap in healthcare technology. Our patented AI/ML algorithms analyze vast amounts of clinical data to predict infection-causing organisms and their resistance patterns, ensuring that healthcare professionals can make informed decisions with confidence.
AMRx® harnesses the power of Artificial Intelligence and Machine Learning to deliver precise predictions in real-time. By analyzing clinical parameters and leveraging clinical metadata of the large number of deidentified patient records, AMRx® offers a level of insight that is unmatched by conventional diagnostic tools.
From organism prediction to antibiotic effectiveness, AMRx® provides a complete suite of tools for managing AMR. Whether it’s drug discovery, drug repurposing, or real-world evidence collection, AMRx® offers a comprehensive solution that supports every stage of antimicrobial management.
AMRx® is designed with versatility in mind. Its culture-free diagnostic capabilities make it an ideal tool for resource-limited settings, where access to advanced lab facilities may be restricted. AMRx® reduces the need for extensive clinical investigations, saving time, effort, and resources while ensuring early prognosis and treatment.
AMRx® is complemented by our cutting-edge AMRx Lab, which uses state-of-the-art tools like whole-genome sequencing and transcriptomics. This integration of advanced laboratory techniques with AI/ML ensures that our solution remains at the forefront of AMR research and intervention.
AMRx® has been validated through extensive trials across multiple tertiary care hospitals. Its reliability and efficacy are well-established, making it a trusted tool for clinicians and healthcare providers worldwide.
AMRx® is more than just a diagnostic tool; it’s a clinical decision support system that empowers healthcare professionals to make evidence-based, patient-centric decisions. By providing real-time insights into the probability of resistant strains, AMRx® enables optimized, cautious, and effective treatment strategies
Choosing AMRx® means choosing the future of infectious disease diagnosis and management. With its unique combination of AI-driven precision, patented technology, and comprehensive support, AMRx® is poised to transform the way we approach and manage Antimicrobial Resistance on a global scale.
From organism prediction to antibiotic effectiveness, AMRx® provides a complete suite of tools for managing AMR. Whether it’s drug discovery, drug repurposing, or real-world evidence collection, AMRx® offers a comprehensive solution that supports every stage of antimicrobial management.
AMRx® is designed with versatility in mind. Its culture-free diagnostic capabilities make it an ideal tool for resource-limited settings, where access to advanced lab facilities may be restricted. AMRx® reduces the need for extensive clinical investigations, saving time, effort, and resources while ensuring early prognosis and treatment.
AMRx® is complemented by our cutting-edge AMRx Lab, which uses state-of-the-art tools like whole-genome sequencing and transcriptomics. This integration of advanced laboratory techniques with AI/ML ensures that our solution remains at the forefront of AMR research and intervention.
AMRx® has been validated through extensive trials across multiple tertiary care hospitals. Its reliability and efficacy are well-established, making it a trusted tool for clinicians and healthcare providers worldwide.
AMRx® is more than just a diagnostic tool; it’s a clinical decision support system that empowers healthcare professionals to make evidence-based, patient-centric decisions. By providing real-time insights into the probability of resistant strains, AMRx® enables optimized, cautious, and effective treatment strategies
State-of-the-Art Research for Advanced solutions to contain Antimicrobial resistance
The AMR Lab is dedicated to advancing our understanding of AMR through cutting-edge research and innovation. Utilizing state-of-the-art technologies such as whole-genome sequencing, transcriptomics, and AI/ML analytics, the lab is focused on deciphering the mechanisms inorder to mitigate the impact of Antimicrobial resistance and support global healthcare community.
